Cite
HARVARD Citation
Ananthakrishnan, A. et al. (2017). The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease. Alimentary pharmacology & therapeutics. 46 (2), pp. 162-168. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ananthakrishnan, A. et al. (2017). The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease. Alimentary pharmacology & therapeutics. 46 (2), pp. 162-168. [Online].